Therefore, it is highly significant to conduct a placebo-controlled intervention study on the effect of imeglimin on exercise tolerance in patients with diabetic HF to improve their prognosis and quality of life.
← all excerpts
Pharmacological interventions to enhance exercise capacity in patients with heart failure.
1
—
—